Sec. 1003. Pandemic Preparedness and Resilience National Security Fund
394 words·~2 min read·
/bill/116/hr/6395/rh/section-1003·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Amounts authorized to be appropriated for Research and Development, Defense-Wide, Pandemic Preparedness and Resilience National Security Fund shall be available for obligation and expenditure only for the purposes of pandemic preparedness. Such amounts may not be used for a purpose or program unless the purpose or program is authorized by law. Amounts referred to in subsection
(a)may be transferred as follows: To Procurement, Defense-wide and Research, Development, Test, and Evaluation, Defense-wide, not more than an aggregate of $200,000,000 to carry out the Small Business Industrial Base Resilience Program established by section 844 of this Act. To Research, Development, Test, and Evaluation, Defense-wide, line 9, Biomedical Technology, not more than $50,000,000 for research that aims to rapidly produce medical countermeasures against novel threats, at population scale and approved for use in people. To the following, not more than an aggregate of $750,000,000 to support research and development efforts directly related to biopreparedness and pandemic preparedness and resilience: Research, Development, Test, and Evaluation, Army. Research, Development, Test, and Evaluation, Navy. Research, Development, Test, and Evaluation, Air Force. Research, Development, Test, and Evaluation, Defense-wide. Defense Health Program. To Research, development, test, and evaluation, Defense-wide, Line 16, Chemical and Biological Defense Program, not more than $27,000,000 for research and development to detect and model treatments for nuclear, chemical, and biological exposure. To research, development, test, and evaluation, Defense-wide, line 44, Chemical and Biological Defense Program – Advanced Development, not more than $30,000,000 for the development of decontamination technologies for civilian pandemic preparedness. To research, development, test, and evaluation, Defense-wide, line 49, Manufacturing Science and Technology Program, not more than $35,000,000 for support for the development of advanced manufacturing techniques and technologies that enable the United States defense industrial base to rapidly produce needed materials for novel biological threats. Amounts referred to in subsection
(a)may not be transferred for— Drug Interdiction and Counter-Drug Activities; or military construction (as defined in section 2801(a) of title 10, United States Code), including the purposes described in section 2802(b) of such title, or military family housing, including the purposes described in section 2821(a) of such title. Not later than 30 days before transferring any amount described in subsection (a), the Secretary of Defense shall submit to the congressional defense committees notice of the transfer. A transfer under this subsection shall not be counted toward the dollar amount limitation under section 1001.